Related references
Note: Only part of the references are listed.Quantitative Molecular Imaging of Viral Therapy for Pancreatic Cancer Using an Engineered Measles Virus Expressing the Sodium-Iodide Symporter Reporter Gene
Stephanie K. Carlson et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2009)
Engineered Measles Virus as a Novel Oncolytic Therapy Against Prostate Cancer
Pavlos Msaouel et al.
PROSTATE (2009)
Measles virus induces oncolysis of mesothelioma cells and allows dendritic cells to cross-prime tumor-specific CD8 response
Anne Gauvrit et al.
CANCER RESEARCH (2008)
Measles virus as an oncolytic vector platform
Boris Blechacz et al.
CURRENT GENE THERAPY (2008)
Oncolytic measles virus strains in the treatment of gliomas
Cory Allen et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial
Martin F. Muers et al.
LANCET (2008)
Chemotherapy for malignant pleural mesothelioma
Nicholas J. Vogelzang
LANCET (2008)
Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases
Monica Neri et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2008)
Preclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamide
R. M. Myers et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus
David H. Kirn et al.
PLOS MEDICINE (2007)
A phase I clinical trial of single-dose intrapleural IFN-β gene transfer for malignant pleural mesothelioma and metastatic pleural effusions:: High rate of antitumor immune responses
Daniel H. Sterman et al.
CLINICAL CANCER RESEARCH (2007)
Viruses as anticancer drugs
Stephen J. Russell et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Stem cell collection and gene transfer in Fanconi anemia
Patrick F. Kelly et al.
MOLECULAR THERAPY (2007)
In vivo quantitation of intratumoral radioisotope uptake using micro-single photon emission computed tomography/computed tomography
Stephanie K. Carlson et al.
MOLECULAR IMAGING AND BIOLOGY (2006)
Survival benefit with imatinib mesylate versus interferon-α-based regimens in newly diagnosed chronic-phase chronic myelogenous leukemia
Hagop M. Kantarjian et al.
BLOOD (2006)
Oncolytic measles virus targets high CD46 expression on multiple myeloma cells
Hooi Tin Ong et al.
EXPERIMENTAL HEMATOLOGY (2006)
Dual therapy of ovarian cancer using measles viruses expressing carcinoembryonic antigen and sodium iodide symporter
K Hasegawa et al.
CLINICAL CANCER RESEARCH (2006)
Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity
CW Chan et al.
NATURE MEDICINE (2006)
Recent progress in the battle between oncolytic viruses and tumours
KA Parato et al.
NATURE REVIEWS CANCER (2005)
Intrapulmonary IFN-β gene therapy using an adenoviral vector is highly effective in a murine orthotopic model of bronchogenic adenocarcinoma of the lung
MJ Wilderman et al.
CANCER RESEARCH (2005)
Rescue and propagation of fully retargeted oncolytic measles viruses
T Nakamura et al.
NATURE BIOTECHNOLOGY (2005)
Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter
D Dingli et al.
BLOOD (2004)
High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus
BD Anderson et al.
CANCER RESEARCH (2004)
Therapeutic effect of intravenous delivery of lipoplexes containing the interferon-β gene and poly I: poly C in a murine lung metastasis model
F Sakurai et al.
CANCER GENE THERAPY (2003)
Development of recombinant vesicular stomatitis viruses that exploit defects in host defense to augment specific oncolytic activity
M Obuchi et al.
JOURNAL OF VIROLOGY (2003)
In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomas
JY Cho et al.
GENE THERAPY (2002)
Links between innate and adaptive immunity via type I interferon
A Le Bon et al.
CURRENT OPINION IN IMMUNOLOGY (2002)
Adenovirus-mediated interferon-ß gene therapy suppresses growth and metastasis of human prostate cancer in nude mice
GW Cao et al.
CANCER GENE THERAPY (2001)
IFN-β gene therapy induces systemic antitumor immunity against malignant glioma
A Natsume et al.
JOURNAL OF NEURO-ONCOLOGY (2000)
Share Paper
